MTOR and renal carcinoma: It was demonstrated that HSF1 activation by mTOR (mammalian target of rapamycin) leads to higher expression of cancer stem-like cell markers by activating DNAJB8, which, in turn, enhances the expression of Sox2 in renal carcinoma cells under stressful conditions [36].